Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
5650studies shown
Showing 4,693-4,704 of 5,650
Behavioral study icon
RecruitingNCT07060742

Study on the Use of Exergames to Support Older Adults With Psychosis

This study is looking at whether a digital support tool can help people with Psychosis, Exergaming, or Elderly. Participants take part in a digital support tool and complete follow-up assessments.

In Basel
SchizophreniaBehavioralOver 55 Years
Countries
Switzerland
Sponsor
Tobias Melcher
Condition
Schizophrenia
Behavioral study icon
RecruitingNCT06590025

INtegral Cognitive REMediation Program for depression

This study is recruiting in Spain. It is testing INtegral Cognitive REMediation Program for depression.

In Barcelona
DepressionBehavioralOver 18 Years
Countries
Spain
Sponsor
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Condition
Depression
Behavioral study icon
RecruitingISRCTN14652885

Study to adapt and assess the feasibility of group interpersonal therapy in Nepal

This study is looking at whether a digital support tool can help people with Depression or Mental and Behavioural Disorders. Participants take part in the therapy or support program and complete follow-up questionnaires or assessments.

In Nepal
DepressionOtherFrom 13 Years to 19 Years
Countries
Nepal
Sponsor
UK Research and Innovation
Condition
Depression
Behavioral study icon
RecruitingNCT06846320

Adverse Events and Change for anxiety

This study is recruiting in the United States. It is testing adverse Events and Change for anxiety.

Multiple locations, including Huntsville
AnxietyBehavioralFrom 18 Years to 65 Years
Countries
United States
Sponsor
AbbVie
Condition
Anxiety
Drug study icon
RecruitingNCT07220460

Adverse Events of Oral ABBV-932 for depression

This study is recruiting in the United States. It is testing Adverse Events of Oral ABBV-932 for depression.

Multiple locations, including Phoenix
Bipolarity, DepressionDrugA study involving a medication or substance.From 18 Years to 65 Years
Countries
United States
Sponsor
AbbVie
Condition
Bipolarity, Depression
Drug study icon
RecruitingNCT06786624

NBI-1065845 for depression

This study is recruiting in the United States. It is testing NBI-1065845 for depression.

Multiple locations, including Little Rock
DepressionDrugOver 18 Years
Countries
United States
Sponsor
Neurocrine Biosciences
Condition
Depression
Drug study icon
RecruitingNCT07467993

Safety, Tolerability, and Treatment Response of GXV813 for schizophrenia

This study is recruiting in the United States and in Bulgaria. It is testing Safety, Tolerability, and Treatment Response of GXV813 for schizophrenia.

Multiple locations, including Bentonville
SchizophreniaDrugFrom 18 Years to 65 Years
Countries
United States, Bulgaria
Sponsor
Novartis Pharmaceuticals
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.